Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Application of Immunohistochemistry in the Classification of Salivary Gland Tumors (Part 3)

Introduction:The previous two articles provided a relatively detailed introduction to the application of immunohistochemistry in the di...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

A Brief Discussion on AE1/AE3, One of the Essential “All-Purpose” Antibodies in Immunohistochemistry

Introduction:AE1/AE3, also known as "CK(Pan)", is one of the essential "all-purpose" antibodies in immunohistochemistry. As a broad-spe...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Cancer Talk: Sun-Induced Skin Cancer

Introduction:Inthe scorching heat of midsummer, many women take sun protection measures to prevent their skin from tanning, but there a...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Fuck Off, Tumor: A Self-Narrative of Triple-Negative Breast Cancer

Introduction:Breast cancer is the most common malignant tumor among women worldwide, with the triple-negative subtype being highly aggr...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Application and Pitfalls of Immunohistochemical Antibodies in Diagnosing Urogenital Diseases (Part 2)

Introduction:The application of immunohistochemical antibodies in the genitourinary system is becoming increasingly common. When biopsy...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Maimai’s Pathology Weekly Reading Notes Issue 9 | Immunohistochemical Markers for Oral Tumors and Salivary Gland Tumors

Preface:When it comes to the types of oral and salivary gland tumors, there are many confusing and hard-to-remember termsthat always co...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Twenty-fourth Issue of “Mai Mai” Pathology Weekly Reading Notes | Overview of Immunohistochemical Markers for Peritoneal Tumor Diagnosis

Preface:Peritoneal neoplastic lesions can be subdivided into primary peritoneal tumors and secondary peritoneal tumors. Primary periton...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

MUC5AC: A Prognostic Indicator for Multiple Tumors

Introduction:Mucin 5AC (MUC5AC) is a secreted glycoprotein with a complex glycosylation structure. Studies have shown that abnormal exp...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Technique Guide: Removing “Water Droplets” from Tissue Sections

Preface:Qualified sections are the prerequisite for pathological diagnosis. Often, the prepared sections are not perfect, such as gaps ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Week 25 of “Mai Mai” Pathology Reading Notes | Overview of Immunohistochemical Markers for Lymphoid Neoplasms Diagnosis (Part 1)

Preface:Lymphoid tissue tumors include lymphomas and tumors derived from other cells in lymphoid tissue, such as histiocytes and dendri...
Continue reading
  • «
  • ‹
  • 8
  • 9
  • 10
  • 11
  • 12
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar